Autopsy report · NCT05561777
Penicillin Allergy Risk-Stratification and Delabeling of Low-Risk Patients
Cause of deathStaffing, sites or logistics
“screening challenges that prevented the intervention from being implemented”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- Vanderbilt University Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Antibiotic Allergy
- Interventions
- Physician-targeted CDS tool for PCN allergy delabeling
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease
“study intervention was approved by the FDA” - Adverse Events of MRI With Abandoned Leads
“The study was stopped due to challenges with recruitment and insufficient insurance coverage for the required procedures, which prevented continuation of the trial.” - Use of Sucrose to Relieve Pain During Eye Exams in Infants
“results did not show intervention was beneficial” - Ketamine for the Treatment for Alcohol Use Disorder in the ED
“After months of screening, we screened 175 individuals, only 3 were eligible, 2 declined, and 1 was moved to a different floor before study activities were able to take place.” - Improving Treatment for Children With Intellectual and Developmental Disabilities and Problem Behavior in Schools
“Insufficient resources to implement intervention”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.